Bargou et al. assessed the efficacy of blinatumomab—an antibody with dual specificity for CD19 and CD3 antigens—in patients with non-Hodgkin lymphoma who relapsed after standard treatments.
Immunotherapies for non-Hodgkin lymphoma and chronic lymphocytic leukaemia ... to the B cell through the CD20 receptor, the signal causes the B cell to die 3. These mechanisms are shown in more ...
Non-Hodgkin lymphoma (NHL) is a cancer affecting the immune system ... However, they can’t distinguish cancer cells from normal, healthy fast-growing cells in the body – this is what causes the ...
miscellaneous causes and undiagnosed causes. Tuberculosis, lymphoma and adult-onset Still's disease are the main diseases among infections, cancers and noninfectious inflammatory diseases ...
It includes the lymph nodes, spleen, thymus gland and bone marrow. The main types of lymphoma are Hodgkin’s lymphoma and non-Hodgkin’s lymphoma. Many types of treatments exist for lymphoma.
Primary non-Hodgkin's lymphoma of the breast (PBNHL) is uncommon. There have been only a few reports of breast lymphoma in the radiology literature. In this case report, we describe mammographic ...